In a randomized placebo-controlled human trial, daily oral intake of 9 mg capsinoids for 6 weeks increased supraclavicular BAT vascular density and showed a trend toward elevated resting energy expenditure, selectively in subjects with detectable baseline BAT activity [ 117 ].
← all excerpts
UCP1-Dependent Thermogenic Adipose Tissue in Human Disease: Adipose-Centered Mechanisms, Biomarker Limitations, and Translational Perspectives.
1
—
—